Purple Biotech PPBT
NASDAQ PPBT
$1.78 -0.06 (-3.37%)
As of: Sep 10, 2026 · 2:14 PM EDT

Purple Biotech (PPBT) Prepaid Assets (2016 - 2026)

Purple Biotech's (PPBT) quarterly Prepaid Assets came in at $485000.0 in Q2 2026, up 23.1% year-over-year from $394000.0 in Q2 2025, and up 37.39% quarter-over-quarter from $353000.0 in Q1 2026.

Analysis

Purple Biotech (PPBT) Prepaid Assets (2016 - 2026) Analysis & Trends

Purple Biotech (PPBT) has reported Prepaid Assets for 11 consecutive years, with $485000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Prepaid Assets rose 23.1% year-over-year to $485000.0 in Q2 2026; TTM through Jun 2026 was $485000.0, a 23.1% increase from a year earlier, with the FY2025 full-year figure at $292000.0, down 23.96% from the prior year.
  • Prepaid Assets was $485000.0 for Q2 2026 at Purple Biotech, up from $353000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $2.4 million in Q1 2022 and troughed at $292000.0 in Q4 2025.
  • A 5-year average of $763833.3 and a median of $516500.0 in 2024 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets surged 57.96% in 2022 and plunged 67.1% in 2023, its largest moves.
  • Over 5 years, Prepaid Assets stood at $1.1 million in 2022, then sank by 67.1% to $376000.0 in 2023, then gained by 2.13% to $384000.0 in 2024, then dropped by 23.96% to $292000.0 in 2025, then jumped by 66.1% to $485000.0 in 2026.
  • The last three Prepaid Assets figures came in at $485000.0 (Q2 2026), $353000.0 (Q1 2026), and $292000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.46 Bn 192.47 Bn 7.24 Bn
2 Gilead Sciences 179.92 Bn 176.75 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.37 Bn 123.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.86 Bn 73.87 Bn 3.93 Bn
5 Argenx Se 60.29 Bn 55.10 Bn 1.37 Bn
6 Moderna 53.76 Bn 48.62 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.16 Bn 29.85 Bn 992.69 Mn
8 Biogen 31.90 Bn 30.62 Bn 1.96 Bn
9 Roivant Sciences 29.13 Bn 29.13 Bn 1.16 Mn
10 Purple Biotech 291,843.46 291,843.46 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 485,000.00
Mar 31, 2026 353,000.00
Dec 31, 2025 292,000.00
Sep 30, 2025 320,000.00
Jun 30, 2025 394,000.00
Mar 31, 2025 428,000.00
Dec 31, 2024 384,000.00
Sep 30, 2024 638,000.00
Jun 30, 2024 473,000.00
Mar 31, 2024 548,000.00
Dec 31, 2023 376,000.00
Sep 30, 2023 634,000.00
Jun 30, 2023 984,000.00
Mar 31, 2023 1.29 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 1.22 Mn
Jun 30, 2022 1.43 Mn
Mar 31, 2022 2.35 Mn
Dec 31, 2021 1.27 Mn
Sep 30, 2021 1.13 Mn